跳至主要内容
临床试验/NCT06934577
NCT06934577招募中不适用

Michigan Screening and Intervention for Glaucoma and Eye Health Through Telemedicine- SIGHT 2: A Pragmatic Randomized Trial

University of Michigan1 个研究点 分布在 1 个国家目标入组 900 人开始时间: 2025年12月4日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
900
试验地点
1
主要终点
Rate of vision threatening eye disease (glaucoma/suspected glaucoma, visually significant cataract, diabetic retinopathy)

研究概览

简要总结

To compare eye disease detection rates at a Federally Qualified Health Center between a technology-enhanced protocol and standard optometric clinical examination for three of the leading causes of blindness: glaucoma, diabetic retinopathy, and visually significant cataract.

详细描述

See study protocol.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
Single (Outcomes Assessor)

盲法说明

The statistician assessing the main outcome measure will be masked. A second statistician, not masked to treatment allocation, will tabulate weekly reports of adverse events by treatment group for review by the medical monitor.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Speak English, Spanish, Arabic, Chinese, French, Hindi, Finnish, Albanian, Russian or Tagalog

排除标准

  • •significant eye pain
  • •sudden decrease in vision within one week
  • •binocular diplopia
  • •cognitive impairment
  • •pregnancy
  • •previously declined participation

研究组 & 干预措施

Control, standard optometric examination

Experimental

Participants will receive usual care with an optometrist with a biomicroscopic exam at the Federally Qualified Health Center to identify eye disease.

干预措施: Technology enhanced eye disease detection protocol (Other)

Control, standard optometric examination

Experimental

Participants will receive usual care with an optometrist with a biomicroscopic exam at the Federally Qualified Health Center to identify eye disease.

干预措施: Standard optometric examination (Other)

Intervention, technology enhanced eye disease detection protocol

Experimental

Participants will receive a technology enhanced eye disease detection protocol from ophthalmic technicians that includes measurements of visual function such as visual acuity, refraction, intraocular pressure, pachymetry, external eye and fundus photography, and optical coherence tomography of the macula and retinal nerve fiber layer. The optometrist at the Federally. Qualified Health Center will then use a protocol to grade the testing and identify eye disease. The results of the grading will inform whether the person receives a brief appointment with the optometrist (if no disease is detected) or an in-depth appointment with the optometrist (if there is disease detected).

干预措施: Standard optometric examination (Other)

Intervention, technology enhanced eye disease detection protocol

Experimental

Participants will receive a technology enhanced eye disease detection protocol from ophthalmic technicians that includes measurements of visual function such as visual acuity, refraction, intraocular pressure, pachymetry, external eye and fundus photography, and optical coherence tomography of the macula and retinal nerve fiber layer. The optometrist at the Federally. Qualified Health Center will then use a protocol to grade the testing and identify eye disease. The results of the grading will inform whether the person receives a brief appointment with the optometrist (if no disease is detected) or an in-depth appointment with the optometrist (if there is disease detected).

干预措施: Technology enhanced eye disease detection protocol (Other)

结局指标

主要结局

Rate of vision threatening eye disease (glaucoma/suspected glaucoma, visually significant cataract, diabetic retinopathy)

时间窗: Visit 1(day 1)

Rate of glaucoma/suspected glaucoma

时间窗: Visit 1 (Day 1)

Rate of visually significant cataract

时间窗: Visit 1(day 1)

Visually significant cataract is defined as presence of cataract with best corrected visual acuity ≤ 20/40 in the absence of other pathology.

Rate of diabetic retinopathy

时间窗: Visit 1(day 1)

次要结局

  • Visual Function(6 weeks)
  • Rate of disease in second allocation(6 weeks)
  • Visual Function(6 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Paula Anne Newman-Casey

Professor of Ophthalmology and Visual Sciences

University of Michigan

研究点 (1)

Loading locations...

相似试验

Michigan Screening and Intervention for Glaucoma and... | 临床试验